Avi Friedlich, MD, Case Western Reserve University

Psychiatry Harvard University, Cambridge, MA, United States 
Alzheimer disease
"Avi Friedlich"




Cross-listing: Neurotree - Neuropathology Tree

BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Friedlich AL. (2012) Neocortical levels of lithium are increased in bipolar disorder. Molecular Psychiatry. 17: 3-4
Bonda DJ, Lee HP, Lee HG, et al. (2010) Novel therapeutics for Alzheimer's disease: an update. Current Opinion in Drug Discovery & Development. 13: 235-46
Friedlich AL, Rolston RK, Zhu X, et al. (2009) Treatment advances in Alzheimer's disease based on the oxidative stress model. F1000 Medicine Reports. 1
Yi J, Horky LL, Friedlich AL, et al. (2009) L-Arginine and Alzheimer's disase International Journal of Clinical and Experimental Pathology. 2: 211-238
Rogers JT, Bush AI, Cho HH, et al. (2008) Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's disease. Biochemical Society Transactions. 36: 1282-7
Friedlich AL, Tanzi RE, Rogers JT. (2007) The 5'-untranslated region of Parkinson's disease alpha-synuclein messengerRNA contains a predicted iron responsive element. Molecular Psychiatry. 12: 222-3
Puglielli L, Friedlich AL, Setchell KD, et al. (2005) Alzheimer disease beta-amyloid activity mimics cholesterol oxidase. The Journal of Clinical Investigation. 115: 2556-63
Friedlich AL, Bush AI. (2005) Copper and zinc in Alzheimer's disease and amyotrophic lateral sclerosis Neurodegenerative Diseases: Neurobiology, Pathogenesis and Therapeutics. 157-165
Friedlich AL, Lee JY, van Groen T, et al. (2004) Neuronal zinc exchange with the blood vessel wall promotes cerebral amyloid angiopathy in an animal model of Alzheimer's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 3453-9
Andreassen OA, Dedeoglu A, Ferrante RJ, et al. (2001) Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease. Neurobiology of Disease. 8: 479-91
See more...